Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Eur J Prev Cardiol. 2014 Sep 17;22(12):1609–1617. doi: 10.1177/2047487314550803

Table 2.

Reasons for which subjects did not meet the eligibility criteria, n (%)

Polypill arm, n=812, 19.2% Minimal care arm, n=760, 18.2%
Hypersensitivity to one of components of polypill 12(0.28) 7(0.17)
History of angioedema 1(0.02) 1(0.02)
History of gastrointestinal bleeding or peptic ulcer disease in last 3 months 13(0.31) 12(0.29)
History of stroke 37(0.87) 58(1.39)
Pregnancy or lactation - -
Bleeding disorders such as hemophilia 1(0.02) 1(0.02)
Regular anticoagulant use 25(0.59) 16(0.38)
Alcohol consumption 2(0.05) 1(0.02)
Advanced liver disease 25(0.59) 18(0.43)
Uncontrolled seizures 10(0.24) 14(0.34)
Severe asthma 108(2.55) 143(3.42)
History of gout 2(0.05) 1(0.02)
Serum creatinine > 2 mg/dL 27(0.64) 31(0.74)
Glomerular filtration rate < 30 ml/min 52(1.23) 64(1.53)
Hemoglobin<10 mg/dL in females and <11 mg/dL in males 210(4.96) 191(4.57)
Systolic blood pressure <90 mmHg and diastolic blood pressure < 60 mmHg 91(2.15) 37(0.89)
Medical/psychiatric comorbidities 305(7.21) 309(7.4)
Unavailability of the subjects 28(0.66) 2(0.05)

Note: Each subject may meet more than one exclusion criterion